Navigation Links
Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
Date:4/8/2013

ics, scientific rigor, and operational efficiency as it moves each of these programs to viable commercialization.

The Company is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com.

NOTE: This announcement may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements, among others, relating to our future capital requirements and the sufficiency of our current assets to meet these requirements, our future results of operations, our expectations for and timing of ongoing or future clinical trials and regulatory approvals for any of our product candidates, and our plans, objectives, expectations and intentions. Because these statements apply to future events, they are subject to risks and uncertainties. When used in this announcement, the words "anticipate", "believe", "estimate", "expect", "expectation", "should", "would", "project", "plan", "predict", "intend" and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to us and are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance or achievements to differ materially from those projected in, or implied by, these forward-looking statements. Factors that may cause such a difference include, without limitation, our need for substantial additional financing and the availability and terms of any such financing, the safety and/or efficacy results of clinical trials of our product candidates, our failure to obtain regulatory approvals or comply with ongoing
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmacyclics, Inc. Prices Public Offering of Common Stock
2. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
3. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
4. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
5. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
6. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
7. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
8. scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
9. Hanger, Inc. Announces First Quarter 2013 Earnings Release And Conference Call
10. Sigma-Aldrich Announces Q1 2013 Earnings Conference Call
11. Uroplasty Announces CEO Resignation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)...  Mobility Ventures LLC, an AM General Company, is ... (NYSE: BAC ) that will make it ... revolutionary MV-1 - - the world,s first and only ... provide safe and comfortable transportation for all passengers including ... purchase a new MV-1 vehicle at the over 150 ...
(Date:2/26/2015)... 26, 2015 LifeScienceIndustryResearch.com adds ... -In- Class Innovations and Cost Optimization Plays Major ... Pharmaceutical Companies research report to the pharmaceuticals intelligence ... this Global Pharma US & EU Outlook 2015 ... divestment of non-core assets result in healthy cash ...
(Date:2/26/2015)... , Feb. 26, 2015  Spring Bank Pharmaceuticals, ... for the treatment of virus infections, today announced ... been appointed Vice President of Finance, a newly ... financial and administrative activities, including financial planning and ... Douglas J. Jensen , President and CEO. ...
Breaking Medicine Technology:Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4Jonathan P. Freve, CPA, Joins Spring Bank Pharmaceuticals as Vice President of Finance 2
... Cempra Pharmaceuticals announced that Carl Foster has been ... Foster will be focusing on business development activities ... the next-generation fluoroketolide solithromycin (CEM-101), that is in ... (CABP), and TAKSTATM (CEM-102 or fusidic acid), that ...
... 2011 Carbylan BioSurgery, Inc. announced today the completion ... trial to evaluate the safety and effectiveness of two ... in patients with osteoarthritis of the knee.   Hydros ... combination products. "Hydros and Hydros TA are ...
Cached Medicine Technology:Cempra Pharmaceuticals Names Carl Foster Executive Vice President of Business Development 2Carbylan BioSurgery Completes Enrollment in Key Clinical Feasibility Study of Hydros and Hydros TA in Patients With Pain From Knee Osteoarthritis; Core Patent Issued 2Carbylan BioSurgery Completes Enrollment in Key Clinical Feasibility Study of Hydros and Hydros TA in Patients With Pain From Knee Osteoarthritis; Core Patent Issued 3
(Date:2/26/2015)... February 26, 2015 Software and ... FDA’s Position and Best Practices for Compliance, **Presented ... Bethesda, MD, http://www.fdanews.com/SoftwareAndCybersecurity , This workshop ... — has been specifically designed to provide attendees ... effectively assure medical device software safety. , In ...
(Date:2/26/2015)... 2015 Deep Market Research Report ... in-depth study on the current state of the ... on the Chinese situation. , Major companies included ... Co.KG, Hu-Friedy, Medisporex, Towne Brothers, Teleflex Medical, Landanger, ... Medical Equipment, Shuanglu, Changshu Henry Medical Instrument, and ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 The ... ) continues to move forward in the U.S. ... LLP reports. According to court records, the proceeding ... 2014. (In Re: Xarelto Products Liability Litigation, No. ... has established standards and procedures pertaining to the ...
(Date:2/26/2015)... CA (PRWEB) February 26, 2015 Artemis ... media partnerships with Pretty Tough and Ink Tip. “Pretty ... to empower women through physical action,” says Wise. “Our ... appreciation of the power of the written word to ... Tough, a media property and lifestyle brand that juxtaposes ...
(Date:2/26/2015)... City, Missouri (PRWEB) February 26, 2015 Soon the ... spoken, viewed and revered again among race fans as the 2015 ... driver Ron Keith returns with a new car, new team and ... semi-pro road racer Ron Keith says, “There’s nothing like the Trans ... for the teams and the audience. Everyone has dreamed of one ...
Breaking Medicine News(10 mins):Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 2Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 3Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 4Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 2Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 3Health News:Federal Xarelto Lawsuits Progress, As Bernstein Liebhard LLP Comments on Issuance of Most Recent Pretrial Order 2Health News:Federal Xarelto Lawsuits Progress, As Bernstein Liebhard LLP Comments on Issuance of Most Recent Pretrial Order 3Health News:Artemis Women In Action Film Festival Announces Media Partnerships with Pretty Tough and Ink Tip 2Health News:Artemis Women In Action Film Festival Announces Media Partnerships with Pretty Tough and Ink Tip 3Health News:Offsite Image Management Hits Trans Am Road Racing Series with New Car, New Team, New Hopes 2Health News:Offsite Image Management Hits Trans Am Road Racing Series with New Car, New Team, New Hopes 3Health News:Offsite Image Management Hits Trans Am Road Racing Series with New Car, New Team, New Hopes 4
... Rebuild Schools and Clinics, LOS ANGELES, May 14 ... relief agency,today announced that it is responding with aid ... earthquake has mobilized relief agencies from,around the world and ... the call., The Chinese Army is taking the ...
... Offers Tips to Help Make Healthy Choices on the ... Swimsuit season is right around the,corner and for many ... though, cutting back on calories and finding time to ... CareerBuilder.com survey reports,that 45 percent of workers have gained ...
... by Johns Hopkins doctors has fine-tuned the dosage and ... patients with strokes caused by bleeding within the brain. ... Stroke Conference in Nice, France, has been shown to ... typically lethal subset of stroke. , "We,ve gone from ...
... children can be picky eaters,spooked by strong flavors or ... the taste of the pickiest eaters. But just because ... family can,t,enjoy something with more zip. To help parents ... without spending all night in the kitchen,Mealtime.org has devised ...
... Stable Treatment for Hemophilia With ... Patients, PRINCETON, N.J., May 13 Novo ... Administration (FDA) has approved,NovoSeven(R) RT (Coagulation Factor VIIa ... recombinant product available,for the treatment of bleeding episodes ...
... Ill., May 13 Z Trim Holdings, Inc.,(Amex: ... statements,for the fiscal year ended December 31, 2007 contained ... accounting,firm, Blackman Kallick LLP. This announcement is being made ... which requires separate disclosure,of receipt of an audit opinion ...
Cached Medicine News:Health News:Forty-Five Percent of U.S. Employees Have Gained Weight at Their Current Jobs, CareerBuilder.com Study Finds 2Health News:Forty-Five Percent of U.S. Employees Have Gained Weight at Their Current Jobs, CareerBuilder.com Study Finds 3Health News:Forty-Five Percent of U.S. Employees Have Gained Weight at Their Current Jobs, CareerBuilder.com Study Finds 4Health News:Researchers fine-tune clot-busting treatment for bleeding in brain 2Health News:Personalized Plates for Picky Palates: Moms can Satisfy all With One Recipe, Four Ways 2Health News:FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors 2Health News:FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors 3Health News:FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors 4Health News:Z Trim Holdings, Inc. Audit Report Contains 'Going Concern' Qualification 2
... first wavefront aberrometer specifically designed to meet ... Practitioner. Utilizing a proprietary, non Hartmann-Shack technology ... accurately measures high order aberrations (3rd-6th order), ... to arrive at a fully optimized prescription ...
... Industrial Laboratories, Inc. specializes in state-of-the-art ... and laboratory specular microscopes, digital video ... digital upgrade package. Our software incorporates ... data correlation with rapid image sequence ...
... friendly computerized medical record system whose goal ... of the practice as well as improve ... provides clinical templates for commonly presenting problems ... contains an exhaustive database to cover rare ...
... applanation tonometer is designed to fit ... or most "Zeiss" style models. This ... intra-ocular pressure readings. The instrument stays ... and the prism is swung down ...
Medicine Products: